Condition
Demodex Blepharitis
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 2 (1)
P 4 (2)
Trial Status
Completed3
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07169461Not ApplicableCompletedPrimary
Effectiveness of Low Level Light Therapy and Intense Pulse Light on Mite Count as Adjuntive Therapies in Demodex Blepharitis Using Artificial Intelligent Program (Ai-Demodex)
NCT07561450Phase 4Not Yet RecruitingPrimary
Demodex Blepharitis in Scleral Lens Wearers
NCT07400965Phase 2RecruitingPrimary
Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis
NCT06182358Phase 4CompletedPrimary
Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers
NCT04780165Not ApplicableCompletedPrimary
Efficacy and Tolerability of Blephademodex Wipes
Showing all 5 trials